The paper demonstrates how the integration of biological systems and advanced technology products forms a new cyborgization market, which is divided into medical and industrial segments, each with its own demand drivers and regulatory requirements. The study presents an analysis of various technologies, from cochlear implants to exoskeletons and neural interfaces, and assesses their commercial potential and degree of implementation. It is shown that the use of NBICS convergence and AI accelerates the development of multifunctional cyborg devices. The relationship between the scale of technology adoption and changes in the employment structure is revealed. Special attention is paid to such economic effects of "mass" cyborgization as increased productivity and the risks of increasing social inequality. The authors draw attention to the need to adapt regulatory institutions and develop management strategies in new technological realities. The work combines systematic and comparative approaches, which allows us to formulate a holistic vision of the prospects and challenges facing this promising industry.